AI CEOs Urge Congress to Require DNA Screening for Bioweapons Risks
The letter says screening and traceability are needed as AI lowers barriers to designing dangerous pathogens, and 1 bipartisan Senate bill already backs the approach.
- On June 4, 2026, AI leaders including OpenAI CEO Sam Altman and Anthropic CEO Dario Amodei signed a public letter urging Congress to mandate customer and order screening for synthetic DNA and RNA providers.
- Signatories warned that rapid AI development erodes historical knowledge barriers, potentially allowing bad actors to design dangerous pathogens and sparking global pandemics.
- Last year, Microsoft researchers demonstrated that AI protein-design tools generated dangerous gene sequences capable of bypassing existing screening software; biosecurity expert David Relman stated, "Given that the screening may fail in some cases, we must then have other points of control."
- A bipartisan Senate bill introduced earlier this year would transition gene synthesis screening from voluntary industry practice to legal requirement, demanding providers verify "customer legitimacy" and scan for "sequences of concern."
- While the International Gene Synthesis Consortium established voluntary screening practices in 2009, experts now argue AI labs must implement additional user controls, a position supported by leaders from Meta and Google DeepMind.
24 Articles
24 Articles
Top AI execs urge Congress to safeguard against biological weapons
Open the article to view the coverage from Bizpac Review
AI executives make rare collective warning on bioweapons threat
AI CEOs Dario Amodei, Demis Hassabis, and Sam Altman — rivals who have publicly been at odds on numerous issues — jointly called for laws to prevent AI being used to create bioweapons. The Anthropic, Google DeepMind, and OpenAI bosses warned that AI systems “outperform PhD-level virologists” on many biotech questions and could be used to make deadly pathogens. Some scholars have warned that bioengineered pandemics along with AI are among the gre…
Sam Altman, Demis Hassabis, Dario Amodei urge tougher controls on synthetic DNA, AI bioweapons
Top AI companies CEOs have been joining hands with security experts and urging for tougher regulations against AI-powered biological threats and synthetic nucleic acids. The most notable chief...
Coverage Details
Bias Distribution
- 46% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
















